Nutrition 21, Inc. (OTCBB: NXXI) has obtained an exclusive license for a patented combination of a probiotic and omega-3 fish oil. The license was obtained from ProbioHealth, LLC and ProbioFerm, LLC, which will allow Nutrition 21 to expand their ingredient portfolio with a novel ingredient blend. The company's newly acquired technology may be an attractive option for companies looking for new product options to overcome the shelf life challenges with probiotics.
Best Damn Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Stock Newsletter
About Nutrition 21
Nutrition 21, Inc. (OTC:BB: NXXI.OB), headquartered in Purchase, NY, is a nutritional bioscience company and the maker of chromium picolinate-based and omega-3 fish oil-based supplements with health benefits substantiated by clinical research. Nutrition 21 holds more than 30 patents for nutrition products and uses. Nutrition 21's portfolio of health and wellness products include: Iceland Health Chromax®, Iceland Health Advanced Memory Formula(TM), Diabetes Essentials(TM), Iceland Health® Maximum Strength Omega-3 and Iceland Health® Joint Relief. The company also manufactures private label supplements and ingredients for third parties. Nutrition 21 distributes its products nationally through more than 29,000 major food, drug and super center retailers as well as internationally.
Sign up for the free Best Damn Penny Stocks newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
About Best Damn Penny Stocks
Best Damn Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
